Inhibition of Hypertrophy, Per Se, May Not Be a Good Therapeutic Strategy in Ventricular Pressure Overload: Other Approaches Could Be More Beneficial
- 21 April 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 131 (16) , 1448-1457
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- Myocardial Recovery and the Failing HeartJACC, 2012
- The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagyNature Communications, 2012
- Pim-1 kinase inhibits pathological injury by promoting cardioprotective signalingJournal of Molecular and Cellular Cardiology, 2011
- Epidemiology and risk profile of heart failureNature Reviews Cardiology, 2010
- Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overloadAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Local energetic regulation of sarcoplasmic and myosin ATPase is differently impaired in rats with heart failureThe Journal of Physiology, 2008
- Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overloadProceedings of the National Academy of Sciences, 2008
- Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in miceJournal of Experimental Medicine, 2007
- Biochemical evidence of myocardial fibrosis in veteran endurance athletesBritish Journal of Sports Medicine, 2007
- Altered energy transfer from mitochondria to sarcoplasmic reticulum after cytoarchitectural perturbations in mice heartsThe Journal of Physiology, 2006